Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Pulmonary Fibrosis Secondary to Systemic Sclerosis

Tundra lists 1 Pulmonary Fibrosis Secondary to Systemic Sclerosis clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06329401

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus placebo on top of standard of care in participants with PPF over 52 weeks.

Gender: All

Ages: 18 Years - Any

Updated: 2026-04-06

80 states

Pulmonary Fibrosis

Progressive Pulmonary Fibrosis

Pulmonary Fibrosis Secondary to Systemic Sclerosis